N6-Methyladenosine (m6A) is well-known for controlling different processes of linear RNA metabolism. Conversely, its role in the biogenesis and function of circular RNAs (circRNAs) is still poorly understood. Here, we characterize circRNA expression in the pathological context of rhabdomyosarcoma (RMS), observing a global increase when compared to wild-type myoblasts. For a set of circRNAs, such an increase is due to the raised expression of the m6A machinery, which we also find to control the proliferation activity of RMS cells. Furthermore, we identify the RNA helicase DDX5 as a mediator of the back-splicing reaction and as a co-factor of the m6A regulatory network. DDX5 and the m6A reader YTHDC1 are shown to interact and to promote the production of a common subset of circRNAs in RMS. In line with the observation that YTHDC1/DDX5 depletion reduces RMS proliferation, our results provide proteins and RNA candidates for the study of rhabdomyosarcoma tumorigenicity.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease due to gradual motoneurons (MN) degeneration. Among the processes associated to ALS pathogenesis, there is the formation of cytoplasmic inclusions produced by aggregation of mutant proteins, among which the RNA binding protein FUS. Here we show that, in neuronal cells and in iPSC-derived MN expressing mutant FUS, such inclusions are significantly reduced in number and dissolve faster when the RNA m6A content is diminished. Interestingly, stress granules formed in ALS conditions showed a distinctive transcriptome with respect to control cells, which reverted to similar to control after m6A downregulation. Notably, cells expressing mutant FUS were characterized by higher m6A levels suggesting a possible link between m6A homeostasis and pathological aggregates. Finally, we show that FUS inclusions are reduced also in patient-derived fibroblasts treated with STM-2457, an inhibitor of METTL3 activity, paving the way for its possible use for counteracting aggregate formation in ALS.
Mechanical alterations of protein condensates are increasingly recognized in the etiology of several neurodegenerative diseases, yet their characterization remains technically challenging. Although Brillouin microscopy could offer a promising solution, its use is hindered by instrumental instabilities demanding frequent adjustments and manual calibrations with reference materials. Here, we present an enhanced Brillouin Microscope that incorporates an electro-optic modulator, serving simultaneously as frequency reference, spectrometer calibrator, and temporal stabilizer. This integration enables robust, real-time spectral stability over multiple days in a fully automated workflow. Using this system, we quantify Brillouin shifts of several protein condensates in living cells and validate our findings with FRAP. The correlation between techniques reveals a fractal internal architecture of the condensates, providing important insights into their physical nature while probing the mechanical behavior of entire compartments containing multiple protein species. Our method offers a unique framework for distinguishing physiological from pathological condensates, paving the way for long-term, user-independent, high-precision mechanical measurements in living cells.
Mechanical alterations of protein condensates are increasingly recognized in the etiology of several neurodegenerative diseases, yet their characterization remains technically challenging. Although Brillouin microscopy could offer a promising solution, its use is hindered by instrumental instabilities demanding frequent adjustments and manual calibrations with reference materials. Here, we present an enhanced Brillouin Microscope that incorporates an electro-optic modulator, serving simultaneously as frequency reference, spectrometer calibrator, and temporal stabilizer. This integration enables robust, real-time spectral stability over multiple days in a fully automated workflow. Using this system, we quantified the mechanical properties of several protein condensates in living cells and validated our findings with FRAP measurements. The correlation between techniques reveals a fractal internal architecture of the protein condensates, providing important insights into their physical nature. Our innovative method thus offers a unique framework for distinguishing physiological from pathological condensates, paving the way for long-term, user-independent and high-precision mechanical measurements in living cells.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder marked by the progressive loss of motor neurons, where aberrant stress granule (SG) dynamics has emerged as a hallmark, especially in cases involving mutations in RNA-binding proteins such as FUS and TDP-43. We previously showed that m 6 A RNA modification is elevated in FUS-associated ALS and that restoring its physiological levels through METTL3 inhibition is sufficient to rescue the aberrant stress granule phenotypes in different human cellular models. Importantly, here we show that reducing m 6 A levels ameliorates locomotor defects and neuromuscular junction (NMJ) abnormalities in Drosophila melanogaster models of ALS expressing the human FUS P525L mutant. Moreover, we demonstrate that the increase in m 6 A is attributable to reduced expression of the m 6 A eraser ALKBH5, resulting from impaired translation caused by direct FUS binding to its transcript. We further show that ALKBH5 downregulation contributes to RNA and protein alterations observed in FUS-associated ALS, driving the abnormal SG dynamics characteristic of the disease. This study supports the hypothesis that restoring correct m 6 A levels could serve as a potential therapeutic strategy for ALS.